GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (NAS:IPA) » Definitions » Total Long-Term Liabilities

IPA (ImmunoPrecise Antibodies) Total Long-Term Liabilities : $7.98 Mil (As of Jan. 2025)


View and export this data going back to 2010. Start your Free Trial

What is ImmunoPrecise Antibodies Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. ImmunoPrecise Antibodies's Total Long-Term Liabilities for the quarter that ended in Jan. 2025 was $7.98 Mil.

ImmunoPrecise Antibodies Total Long-Term Liabilities Historical Data

The historical data trend for ImmunoPrecise Antibodies's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies Total Long-Term Liabilities Chart

ImmunoPrecise Antibodies Annual Data
Trend Dec14 Dec15 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.02 3.17 7.18 10.45 13.12

ImmunoPrecise Antibodies Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.74 13.12 11.14 10.81 7.98

ImmunoPrecise Antibodies Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

ImmunoPrecise Antibodies Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmunoPrecise Antibodies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (NAS:IPA) » Definitions » Total Long-Term Liabilities
Comparable Companies
GDTC DARE CALC TENX KALA PULM GBIO ALXO HRGN OTLC VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
TQB:Germany
Address
Industrious 823 Congress Avenue, Suite 300, Austin, TX, USA, 78701
Website
https://www.ipatherapeutics.com
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.